Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease-Reference-Cited by-同舟云学术

Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease

Published:2022-05-27 Issue:11 Volume:65 Page:7561-7580
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Tan Haozhou¹,Hu Yanmei¹,Jadhav Prakash¹,Tan Bin¹,Wang Jun¹^ORCID

Affiliation:

1. Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, the State University of New Jersey, Piscataway, New Jersey 08854, United States

Funder

National Institute of Allergy and Infectious Diseases

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c00303

Reference111 articles.

1. Human Coronavirus-229E, -OC43, -NL63, and -HKU1 (Coronaviridae)

2. Overview of lethal human coronaviruses

3. Origin and evolution of pathogenic coronaviruses

4. The Novel Human Coronaviruses NL63 and HKU1

5. Epidemiology and Clinical Presentations of the Four Human Coronaviruses 229E, HKU1, NL63, and OC43 Detected over 3 Years Using a Novel Multiplex Real-Time PCR Method

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How many organic small molecules might be used to treat COVID-19? From natural products to synthetic agents;European Journal of Medicinal Chemistry;2024-11

2. SARS-CoV-2 replication and drug discovery;Molecular and Cellular Probes;2024-10

3. Novel compounds with dual inhibition activity against SARS-CoV-2 critical enzymes RdRp and human TMPRSS2;European Journal of Medicinal Chemistry;2024-10

4. Exploring the binding dynamics of covalent inhibitors within active site of PLpro in SARS-CoV-2;Computational Biology and Chemistry;2024-10

5. Molecular Investigations of Novel Pyrano[2,3-c]Pyrazole Congeners as Potential HCoV-229E Inhibitors: synthesis, Molecular Modeling, 3D QSAR, and ADMET Screening;Polycyclic Aromatic Compounds;2024-09-11